多巴胺治疗对全身动力学的影响通过网络理论来探索
Antonella Romano1, Marianna Liparoti2, Roberta Minino1
1Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy.
Scientific reports
|January 22, 2024
概括
在帕金森病 (PD) 中的乐伏多巴治疗通过减少干头同步和改善上下肢协调来改变全身运动,与临床改善相关.
科学领域:
- 生物力学 生物力学
- 神经科学是一个神经科学.
- 系统生物学 系统生物学
背景情况:
- 三维运动分析量化了运动,但往往专注于细分数据.
- 在帕金森病 (PD) 中,复杂的全身动力学变化无法通过传统方法完全捕捉到.
- 网络理论提供了一种新的方法来分析生物系统中的相互联系.
研究的目的:
- 为了研究勒沃多巴对整个身体运动相互作用的作用,在帕金森病 (PD) 的步行过程中.
- 应用网络理论来分析莱沃多巴摄入前后的"动力交互矩阵".
- 为了确定 kinectome 拓学是否预测了PD 患者的临床变异.
主要方法:
- 从23名PD参与者收集了21个身体标记物的步行数据.
- 网络理论应用于加速动力学数据,以创建 kinectomes.
- 用拓分析和多线性回归来评估 kinectome 属性及其与临床评分的相关性.
主要成果:
- 莱沃多巴的摄入降低了PD患者的干部和头部同步 (p<0.05).
- 上下肢同步显著改善了莱沃多巴后 (p<0.005).
- 同步的改善与统一帕金森病评分表第三部分 (UPDRS-III) 评分的变化成正比.
结论:
- 莱沃多巴影响PD的全身步态动态,而不仅仅是孤立的部分.
- kinectome 的网络分析为PD 药物治疗的全身效应提供了洞察力.
- 在服用勒沃多巴后降低的性可能解释了观察到的身体部分协调的变化.
更多相关视频
11:06A Human-machine-interface Integrating Low-cost Sensors with a Neuromuscular Electrical Stimulation System for Post-stroke Balance Rehabilitation
Published on: April 12, 2016
10.5K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
相关概念视频
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
323
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
323
